Sentynl Therapeutics, Inc.
www.sentynl.comSentynl Therapeutics, a wholly owned subsidiary of Zydus Cadila Pharmaceuticals, is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.
Read more
Sentynl Therapeutics, a wholly owned subsidiary of Zydus Cadila Pharmaceuticals, is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.
Read more
Country
State
California
Industry
Employees
11-50
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President , General Counsel and Chief Compliance Officer
Email ****** @****.comPhone (***) ****-****Senior Vice President , Business Development
Email ****** @****.comPhone (***) ****-****Founder and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Senior Director of Rare Disease Marketing
Email ****** @****.comPhone (***) ****-****
Technologies
(6)
Reach decision makers at Sentynl Therapeutics, Inc.
Free credits every month!
Sentynl Therapeutics, Inc. FAQ
Biotechnology Research
